Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 38.80M | 42.19M | 41.42M | 38.95M | 40.88M |
Gross Profit | 18.37M | 17.13M | 16.19M | 15.92M | 17.33M |
EBITDA | -36.71M | 3.32M | 6.48M | 5.91M | 6.42M |
Net Income | -39.29M | 384.00K | 385.00K | 156.00K | -225.00K |
Balance Sheet | |||||
Total Assets | 47.90M | 91.91M | 96.21M | 97.87M | 101.08M |
Cash, Cash Equivalents and Short-Term Investments | 1.85M | 2.01M | 2.65M | 2.46M | 3.61M |
Total Debt | 10.44M | 13.44M | 17.93M | 20.11M | 22.34M |
Total Liabilities | 28.77M | 33.85M | 38.89M | 41.25M | 45.02M |
Stockholders Equity | 19.13M | 58.06M | 57.32M | 56.62M | 56.06M |
Cash Flow | |||||
Free Cash Flow | 4.89M | 7.20M | 5.74M | 4.52M | 9.95M |
Operating Cash Flow | 5.08M | 7.51M | 6.02M | 5.14M | 11.04M |
Investing Cash Flow | -130.00K | -3.64M | -3.56M | -4.04M | -5.56M |
Financing Cash Flow | -5.11M | -7.82M | -2.26M | -2.25M | -4.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £55.83M | 12.48 | 36.26% | 1.12% | 24.67% | 119.90% | |
64 Neutral | £1.85B | 8.98 | -12.54% | 3.82% | 1.42% | -47.57% | |
60 Neutral | £47.10M | 9.61 | -24.72% | 5.07% | -5.93% | ― | |
55 Neutral | £21.74M | 21.05 | 1.01% | ― | -19.00% | ― | |
52 Neutral | £28.49M | ― | -9.50% | ― | -4.28% | 12.79% | |
51 Neutral | £26.87M | 34.88 | -101.80% | ― | -8.03% | -10232.93% |
NAHL Group plc has announced the issuance and allotment of 25,000 new ordinary shares following the exercise of share options by certain employees. This move will increase the Group’s total issued ordinary share capital to 48,201,103 shares, all with one voting right per share, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
NAHL Group plc reported a significant increase in underlying operating profit for the first half of 2025, driven by reduced marketing costs and overheads in its Personal Injury business. The Group also saw a substantial rise in free cash flow, leading to a reduction in net debt. In the Consumer Legal Services division, while revenue slightly decreased, operating profit surged due to strategic investments in new lead generation channels. Meanwhile, the Critical Care division experienced modest revenue growth, with high demand for expert witness services but a decline in case management revenue. The Board is exploring options to enhance shareholder value following the cessation of the sale process for Bush & Co.
NAHL Group Plc, a UK-based company, announced a change in the breakdown of its voting rights, with Harwood Capital LLP now holding 18.94% of the voting rights, down from a previous 19.42%. This change could impact the company’s governance and decision-making processes, potentially affecting its strategic direction and stakeholder interests.
NAHL Group Plc, a UK-based company, has announced a change in its major holdings. Colebrooke Partners IM Limited, based in London, has reduced its voting rights in NAHL Group Plc to less than 3%, down from a previous position of 3.27%. This change in holdings could impact the company’s shareholder dynamics and influence its strategic decisions moving forward.
NAHL Group PLC announced that all resolutions proposed at its Annual General Meeting were passed, reflecting strong shareholder support. The resolutions included the approval of the annual report, directors’ remuneration, auditor appointments, and share allotment authorities, indicating a stable operational outlook and strategic alignment with shareholder interests.
NAHL Group PLC announced at its AGM that the momentum from the first quarter has continued into the second quarter, and the Board remains confident in meeting the full-year market expectations. The company plans to release a trading update for the first half of 2025 in July, indicating a stable outlook and potential positive impact on its operations and market positioning.
NAHL Group plc announced the conclusion of its attempt to sell its Critical Care business, Bush & Co., without a successful transaction. Despite interest from multiple bidders and detailed discussions with two final parties, the proposals did not meet the Board’s expectations for shareholder value. The company is now evaluating its options and will provide updates to shareholders as necessary.
NAHL Group PLC has announced the posting of its Annual Report and Accounts for the year ending 31 December 2024, along with the notice for its upcoming Annual General Meeting (AGM) scheduled for 26 June 2025. The company is offering shareholders the flexibility to attend the AGM online, although online attendees will not be able to vote or participate actively. Shareholders are encouraged to submit proxies early to ensure their votes are counted, and the results will be published post-AGM. This move reflects NAHL’s continued adaptation to modern shareholder engagement practices.
NAHL Group plc has announced the issuance and allotment of 25,000 new ordinary shares following the exercise of share options by certain employees. This move will increase the company’s total issued ordinary share capital to 48,008,103 shares, each with one voting right. The new shares will be admitted to trading on AIM, with dealings expected to commence on 29 May 2025. This development is significant for shareholders as it affects the total number of shares and voting rights, which is crucial for determining changes in shareholding interests under the FCA’s Disclosure Guidance and Transparency Rules.
NAHL Group plc has announced the issuance and allotment of 25,000 new ordinary shares following the exercise of share options by employees. These shares will be admitted to trading on AIM, increasing the company’s total issued ordinary share capital to 47,983,103 shares. This move reflects the company’s ongoing efforts to manage its share capital and could impact shareholder calculations regarding their interests in the company.